Ask AI

Precision in Practice: Navigating AE Mitigation in the Era of Targeted Treatments to Elevate Clinical Outcomes for Patients With High-Risk HR+/HER2- Breast Cancer

Gain expert insights into managing adverse events associated with targeted therapies for high-risk HR-positive/HER2-negative breast cancer to individualize treatment and optimize patient outcomes through a ClinicalThought commentary, certified on-demand webcasts, and downloadable slides.

Share

Program Content

Events

  • Live Event
    Precision in Practice: Navigating AE Mitigation in the Era of Targeted Treatments to Elevate Clinical Outcomes for Patients With High-Risk HR+/HER2- Breast Cancer
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

AE Mitigation for HRpos HER2neg Breast Cancer
Precision in Practice: Navigating AE Mitigation in the Era of Targeted Treatments to Elevate Clinical Outcomes for Patients With High-Risk HR+/HER2- Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 17, 2026

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (Partners) in partnership with Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner